← Back to headlines
Egetis Therapeutics approval looms at Cantor conference
Investors are watching Egetis Therapeutics closely as regulatory approval for its key drug appears imminent following presentations at the Cantor healthcare conference.
11 Sept, 13:50 — 11 Sept, 13:50
Sources
Showing 1 of 1 sources
